Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Allphase Pharma Consulting, LLC
Menu

Primary menu

  • CONTACT
  • BLOGS
    • The Viewpoint
    • The News
    • Recent Literature
    • Did you know…?
    • QIDP Antibiotics
  • LEGAL
  • WELCOME

Secondary menu

  • The News
  • The Viewpoint
  • Did you know…?
  • Recent Literature
  • QIDP Antibiotics

Tag Archives: DHFR inhibitor

QIDP Antibiotics – 2015 Year-End Update

Posted on December 23, 2015 by Harald — No Comments ↓

Here an updated listing of all QIDP drugs we are aware of as of 12/24/2015. Today just facts and numbers; we will provide an interpretation of the current landscape in upcoming blogs. There are 58 drugs which garnered QIDP status and these are listed in the Main Table below. With the recent Continue reading QIDP Antibiotics – 2015 Year-End Update→

Share this:

  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...
Posted in QIDP Antibiotics, The News | Tagged ABSSSI, Allphase Pharma Consulting, aminoglycosides, amphotericin B, antibiotic blog, azole, Beta-lactam, BL/BLI combination, bronchiectasis, CABP, ceftazidime/avibactam / Avycaz, ceftolozane/tazobactam / Zerbaxa, cystic fibrosis, dalbavancin / Dalvance, defensin-mimetic, DHFR inhibitor, enfumafungin, FabI inhibitor, fluoroquinolones, Fusidic Acid, GC, Harald Reinhart, isavuconazole / Cresemba, ketolide, macrolide, MoA, nikkomycin, NTM, oritavancin / Orbactiv, oxazolidinone, pleuromutilin, sulfonamide, tedizolid / Sivextro, tetracycline, topisomerase II-inhibitor, vancomycin, VAP | Leave a reply

Go back

Your message has been sent

Rating(required)
Warning

Footer Menu

Footer menu

  • CONTACT
  • BLOGS
  • LEGAL
  • WELCOME
  • Email
Copyright © 2026 Allphase Pharma Consulting, LLC. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
%d